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University, Princeton NJ 08544ABSTRACT A large and diverse array of small hydrophobic molecules induce general anesthesia. Their efficacy as anes-
thetics has been shown to correlate both with their affinity for a hydrophobic environment and with their potency in inhibiting
certain ligand-gated ion channels. In this study we explore the effects that n-alcohols and other liquid anesthetics have on
the two-dimensional miscibility critical point observed in cell-derived giant plasma membrane vesicles (GPMVs). We show
that anesthetics depress the critical temperature (Tc) of these GPMVs without strongly altering the ratio of the two liquid phases
found below Tc. The magnitude of this affect is consistent across n-alcohols when their concentration is rescaled by the median
anesthetic concentration (AC50) for tadpole anesthesia, but not when plotted against the overall concentration in solution. At
AC50 we see a 4
C downward shift in Tc, much larger than is typically seen in the main chain transition at these anesthetic con-
centrations. GPMV miscibility critical temperatures are also lowered to a similar extent by propofol, phenylethanol, and isopro-
panol when added at anesthetic concentrations, but not by tetradecanol or 2,6 diterbutylphenol, two structural analogs of general
anesthetics that are hydrophobic but have no anesthetic potency. We propose that liquid general anesthetics provide an exper-
imental tool for lowering critical temperatures in plasma membranes of intact cells, which we predict will reduce lipid-mediated
heterogeneity in a way that is complimentary to increasing or decreasing cholesterol. Also, several possible implications of our
results are discussed in the context of current models of anesthetic action on ligand-gated ion channels.INTRODUCTIONA large number of small molecules induce clinically similar
general anesthesia, ranging from the noble gas Xenon to
larger organic molecules. Since the early 20th century it
has been known that the potency of a general anesthetic is
roughly proportional to its oil:water partition coefficient
over more than five orders of magnitude in overall concen-
tration (1,2). This striking correlation along with the struc-
tural diversity of general anesthetics has led many to
speculate that anesthesia is induced through nonspecific
effects on the physical properties of membrane lipids, and
not through specific interactions with proteins. It has been
proposed that this could be accomplished by altering the
pressure profile of the membrane (3), the lateral organiza-
tion of the membrane (4,5), or the mechanical properties
of axonal membranes (6). In support of these theories, gen-
eral anesthetics were shown to decrease lipid chain ordering
(7), increase membrane fluidity (8), alter membrane conduc-
tance (9), and lower the transition temperature into a gel
phase (10–12).
Strong arguments have been made against membrane-
mediated models of general anesthesia over the past several
decades. First, although anesthetics do partition into mem-
branes roughly in proportion to their potency (13), there
are a variety of hydrophobic small molecules that partition
strongly into membranes but have reduced or no anestheticSubmitted September 10, 2013, and accepted for publication November 4,
2013.
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acterized anesthetics (7,14–16). Second, it has been argued
that the effects that anesthetics have on the physical proper-
ties of membranes are too small to be functionally signifi-
cant at their anesthetic dose, as many properties are easily
mimicked by raising temperature <1C (17).
Instead, recent attention has focused on protein models
(18). It is now well known that the function of many
ligand-gated ion channels are sensitive to the presence of
anesthetics (19), and it is widely (though not universally,
see for example (8,64,65)) held that the anesthetic response
is primarily due to the altered functioning of these ligand-
gated channels. Recent experiments have shown that this
sensitivity can be modulated by mutating specific amino
acid residues (20). A recent crystallographic study has local-
ized anesthetics in the vicinity of a proposed binding site of
GLIC, a prokaryotic ligand-gated ion channel that is sensi-
tive to anesthetics, although the resulting structure most
closely resembles the anesthetic destabilized ‘‘open’’ state
(21). These and other related results are widely interpreted
to imply that anesthetics exert their influence on channels
by binding to specific sites on target molecules.
In parallel, the past decade has clarified the functional
roles of lipids in biological processes at the plasma mem-
brane of animal cells. Relevant to the current study, it is
now believed that proteins are not uniformly distributed in
mammalian cell membranes, but that lipids help to laterally
organize proteins into correlated structures with dimensions
ranging between 10 and 100 nm often termed lipid rafts or
lipid shells (22–24). These structures likely arise, at leasthttp://dx.doi.org/10.1016/j.bpj.2013.11.005
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equilibrium liquid phases at low temperatures, called
liquid-ordered (Lo) and liquid-disordered (Ld) (25). We
have recently proposed a model of plasma membrane het-
erogeneity (26) that attributes this structure to the presence
of a miscibility critical point in cell plasma membranes
below growth temperatures (26–29). This model is sup-
ported by experimental observations of critical behavior in
giant plasma membrane vesicles (GPMVs) isolated from
living cells (30,31). This shares essential elements of earlier
models that focus on fluctuations in single component
bilayer membranes in the vicinity of the gel-liquid transition
(27,28) or in single or multicomponent monolayer mem-
branes near a miscibility critical point (29,32,33). All of
these models predict that the size, composition, and life-
time of lipid mediated structures in intact cells at physiolog-
ical temperature will be sensitive to the temperature of the
underlying critical point.
In this study, we explore how liquid general anesthetics
modulate the miscibility transition in plasma membrane
vesicles isolated from RBL-2H3 cells. This work is moti-
vated by past experiments in purified model membranes
that demonstrate that liquid-liquid miscibility transitions
can be more sensitive to small perturbations in composition
(34–38) than the main chain melting transition that has pre-
viously seen extensive study in the context of anesthesia
(10–12). We find that most liquid general anesthetics inves-
tigated lower critical temperatures of the liquid-liquid tran-
sition in GPMVs by roughly 4C at their anesthetic dose,
and by larger amounts at higher concentrations. This modu-
lation is expected to reduce the magnitude of heterogeneity
in plasma membranes at physiological temperature and
could, in principle, suppress the functions of proteins or pro-
tein networks that are sensitive to lipid-mediated structures.
There is some evidence that the localization and function of
ligand-gated ion channels, including some implicated in the
anesthetic response, are sensitive to ‘‘raft’’ heterogeneity
(39–43). This suggests that anesthetics may act, at least in
part, through their effects on membrane miscibility.MATERIALS AND METHODS
Materials
Rat basophilic leukemia (RBL-2H3) cells were a gift from Barbara Baird
and David Holowka. The fluorescent probe DiI-C12 was purchased from
Life Technologies (Carlsbad, CA). Formaldehyde was obtained from
Thermo Fisher Scientific (Waltham, MA). Diththiothreitol, ethanol, 1-prop-
anol, 2-propanol, octanol, decanol, tetradecanol, propofol, phenylethanol,
2,6 ditertbutylphenol, dimethylsulfoxide (DMSO), and all additional
reagents unless otherwise specified were purchased from Sigma Aldrich
(St. Louis, MO).Cells and GPMV preparation
RBL-2H3 cells were grown and maintained with media containing MEM,
20% FBS, 10 mg/ml gentamicin sulfate in 25 cm2 flasks as described previ-Biophysical Journal 105(12) 2751–2759ously (44). Cells were labeled for 10 min with 2 mg/mL DiI-C12 in methanol
(1% final concentration) then GPMVs were prepared as described previ-
ously (25), by incubating cells in a buffer containing 2mM DTT, 25 mM
formaldehyde, 150 mM NaCl, 2 mM CaCl2, and 20 mM HEPES pH 7.4
at 37C for 60 min, after which they were isolated by separating buffer
from adherent cells. GPMVs were treated with anesthetics at the specified
concentrations by diluting GPMV suspensions at most 1:1 into a buffer con-
taining anesthetics for at least 15 min before imaging. In control experi-
ments (no anesthetic added), we observe no effect of diluting GPMV
suspensions into an additional buffer. Tetradecanol and 2,6 ditert-butylphe-
nol were dissolved in DMSO before being added to GPMVs because these
compounds have low water solubility. The maximum final concentration of
DMSO was 14 mM. Significantly higher DMSO concentrations (600 mM)
did not alter results in control experiments, and results were indistinguish-
able within error for GPMVs incubated with 11mM propofol in the presence
or absence of 14 mM DMSO.Fluorescence microscopy
GPMVs were imaged between two No. 1.5 cover slips sealed with a thin
layer of Dow Corning high vacuum grease. Images were acquired using
an inverted microscope (IX81; Olympus, Center Valley, PA) using a 40
0.95 NA air objective, a Cy3 filter-set (Chroma Technology, Bellows Falls,
VT) and an SCMOS camera (Neo; Andor, South Windsor, CT). The sample
chamber was attached to a homebuilt temperature stage consisting of a pelt-
ier thermoelectric device, water-circulating heat sink (Custom Thermoelec-
tric, Bishopville, MD), and a PID-type controller unit (Oven Industries,
Mechanicsburg, PA). The sample was adhered using a thin layer of thermal
grease to a copper plate in thermal contact with one side of the peltier
device. Temperature was measured with a thermister probe mounted on
the copper plate close to the sample.Transition temperature determination
Several (typically five) fields containing numerous GPMVs (10 to 200)
from the same sample were imaged at temperatures ranging from 25 to
5C in increments of 2 to 3C. At each temperature, 200 to 500 GPMVs
were imaged. The percent of GPMVs containing two coexisting liquid
phases (% separated) was determined from images acquired at each temper-
ature (T) using a custom program written in Matlab (MathWorks, Natick,
MA) and errors are given by counting statistics. Critical temperatures
(Tc) are obtained through a nonlinear least squares fit to the following
sigmoidal curve:
%separated ¼ 100 

1 1
1þ eðTTcÞ=B

;
where B is a constant that describes the slope of the curve at the transition
temperature. By this definition, Tc corresponds to the temperature where
50% of vesicles contain coexisting liquid phases. Errors in absolute transi-
tion temperatures (sT) for a single measurement are extracted directly from
the fit.
Absolute critical temperatures for GPMV preparations can show signif-
icant day-to-day variation, therefore we report critical temperature shifts in
the presence of anesthetics compared with a control sample investigated
from the same preparation of GPMVs. The error bounds for a given critical
temperature shift (DTc) is given by sDTc ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2To þ s2T
p
, where sTo is the
error associated with determining the critical temperature of the control
sample and sT is the error associated in determining the critical temperature
of GPMVs with anesthetic. In most cases, we report a critical temperature
shift that is a weighted average of DTc values determined from multiple
experiments conducted on different days (typically three to four). Weights
are given by w ¼ 1
s2i
=
P
1
s2i
, where si is the error for each DTc included in the
average. Error bounds on average points (s) are given by s ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=
P
1
s2i
q
.
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Ethanol lowers critical temperatures in isolated
plasma membrane vesicles
GPMVs isolated from RBL-2H3 cells contain a single liquid
phase at elevated temperatures and coexisting Lo and Ld
phases at low temperatures. Phase separation is easily visu-
alized by monitoring the lateral distribution of the fluores-
cent lipid analog DiI-C12 in GPMVs using conventional
fluorescence microscopy. Although individual GPMVs
have well-defined transition temperatures, there is signifi-
cant variation in transition temperatures between vesicles
isolated from a single flask of cells. For this reason, we
report the average transition temperature for a sample of
GPMVs by determining the fraction of vesicles containing
coexisting phases as a function of temperature, as shown
in Fig. 1. These data are fit by a sigmoid function to extract
the temperature where 50% of vesicles have undergone a
transition, which we report as the transition temperature of
the sample. For the control sample in Fig. 1 A, we extractFIGURE 1 Ethanol lowers transition temperatures in GPMVs. (A)
Untreated GPMVs isolated from a single flask of cells show a broad distribu-
tion of transition temperatures. We quantify average transition temperatures
bymeasuring the fraction of GPMVswith coexisting phases at multiple tem-
peratures (black circles) and fit this distribution to extract the temperature
where 50% of GPMVs contain coexisting liquid phases. When ethanol
(EtOH) is added to vesicles from the same flask of cells before imaging,
the distribution of phase separated vesicles shifts to a lower temperature
(red squares), indicating that the transition temperature is lower. This down-
ward shift in transition temperature is most apparent when comparing fields
of vesicles imaged at 14C in this experiment, where the majority of control
GPMVs contain coexisting liquid phases whereas most ethanol-treated
vesicles are uniform. (B, C) The transition temperature shift is dependent
on the concentration of ethanol incubated with GPMVs. The curves in B
are fit to obtain the average transition temperature reported in C and are
drawn with the same symbols. To see this figure in color, go online.an average transition temperature of 15.9 5 0.3C, where
the error is extracted directly from the fit.
When GPMVs isolated from the same dish of cells are
incubated with ethanol before imaging, we observe the
average transition temperature at a lower value. For the
case of 120 mM ethanol shown in Fig. 1 A, we measure
an average transition temperature of ethanol-treated
GPMVs to be 12.55 0.6C, which represents a downward
shift of DTc ¼ –3.45 0.7C compared with untreated ves-
icles. This shift in average transition temperature is most
apparent when vesicles are visualized at a temperature
where a finite fraction of vesicles are phase-separated in un-
treated GPMVs. When ethanol-treated vesicles are imaged
at this same temperature, many fewer vesicles contain coex-
isting liquid phases. We also find that the magnitude of DTc
depends on the concentration of anesthetic incubated with
GPMVs. Fig. 1 B shows the fraction of phase-separated
GPMVs as a function of temperature for control GPMVs
and GPMVs incubated with 120, 240, or 600 mM ethanol
before imaging, with all GPMVs prepared from the same
flask of cells. Extracted transition temperatures are
shown in Fig. 1 C and are monotonically decreasing with
increasing ethanol concentration, with nonlinearities at
low concentrations. Previous studies have indicated that
ethanol makes up a few mole % of the membrane at the
anesthetic dose (13). The nonlinearities that we observe in
DTc highlight that even small mole fractions of ethanol
can lead to large changes in the physical properties of
GPMV membranes.
In addition to variation of transition temperatures between
vesicles in a given GPMV preparation, we also observe
significant day-to-day variationwhen average transition tem-
peratures are measured. This is demonstrated by comparing
the control curves in Fig. 1, A and B, which yield different
absolute transition temperatures (15.95 0.3C vs. 20.35
0.6C). Even so, we find that the magnitude of the downward
shift in transition temperatures observed after the addition
of liquid general anesthetics is robust. For the example of
incubation with 120 mM ethanol, we observe an average
transition temperature shift of DTc ¼ –3.5 5 0.6C when
averaged over three distinct experiments, where the error is
the standard deviation between the three measurements.Ethanol-treated vesicles retain critical
fluctuations
In addition to undergoing a miscibility transition near room
temperature, untreated GPMVs exhibit robust critical fluctu-
ations within several degrees of their miscibility transition
temperature. The size and contrast of fluctuations in both
synthetic and isolated biological membranes have been
previously shown to be consistent with belonging to the
two-dimensional Ising model universality class (30,45).
Hallmarks of criticality in membranes include micron-sized
and dynamic composition fluctuations within ~1C aboveBiophysical Journal 105(12) 2751–2759
FIGURE 3 Critical temperature shift in GPMVs scales with anesthetic
potency. (A) Measured critical temperature shifts in GPMVs incubated
2754 Gray et al.the miscibility transition temperature and undulating phase
boundaries within several degrees below the miscibility
transition temperature (45,46). Vesicles with critical compo-
sitions also contain roughly equal surface fractions of
phases at temperatures just below the phase transition.
Untreated vesicles show weak temperature dependence in
the surface fraction of coexisting phases, consistent with
their being a nearly vertical rectilinear diameter (26).
Although incubation with different concentrations of
ethanol lowers transition temperatures in GPMVs, hall-
marks of critical behavior are still observed in these vesicles,
albeit at a lower temperature, as shown in Fig. 2. Ethanol-
treated vesicles can be found to contain large and dynamic
composition fluctuations above their transition temperature,
undulating phase boundaries below their transition tempera-
ture, and roughly equal surface fractions of phases in vesi-
cles well below their phase transition temperature. These
results suggest that although membrane composition is
altered through incubation with ethanol, this composition
change acts to shift the critical temperature without shifting
vesicle composition away from a critical composition.with a series of n-alcohol general anesthetics as a function of aqueous con-
centration of n-alcohol. Data points represent a weighted average over mul-
tiple experiments, as described in Methods and error bounds are propagated
through this average. Lines are fits to all points excluding 0mM n-alcohol.
(B) Data from A repotted with concentration scaled by the published
anesthetic dose (AC50) of these compounds (47). To see this figure in color,
go online.Liquid alcohol anesthetics lower critical
temperatures by 4C at their anesthetic dose
Ethanol is a member of a series of n-alcohol general anes-
thetics, and we have also investigated how other compounds
in this series modulate phase transition temperatures and
fluctuations in isolated GPMVs. As summarized in Fig. 3
A, all n-alcohol anesthetics shown lower critical tempera-
tures in GPMVs compared with untreated vesicles isolated
from the same flask of cells although the concentration
required depends strongly on the alcohol used. Longer chainFIGURE 2 Ethanol-treated vesicles retain critical fluctuations. Represen-
tative images of different GPMVs imaged in 120 mM ethanol demon-
strating a range of critical phenomena including dynamic supercritical
fluctuations for T R Tc and phase boundary fluctuations for T % Tc. At
low temperatures (T << Tc), vesicles separate into roughly equal surface
fractions of Lo and Ld phases. Vesicle imaged over a range of temperatures
between 11 and 16C.
Biophysical Journal 105(12) 2751–2759alcohols such as octanol or decanol are the most potent.
Similar to ethanol, GPMVs treated with longer chain n-alco-
hols also retain hallmarks of critical behavior near and
below their transition temperature. As a control, we investi-
gated GPMVs incubated with DMSO, where we observe no
shift in transition temperatures when DMSO is included at
600 mM.
Remarkably, plots of DTc vs. n-alcohol concentration
collapse onto a single curvewithin error when n-alcohol con-
centration is rescaled by their anesthetic potency, as shown in
Fig. 3 B. The anesthetic dose, or AC50 value, is defined as the
anesthetic concentration where 50% of tadpoles lose their
righting reflex, as reported in a previous study (47). AC50
values for the n-alcohols investigated are 120 mM (ethanol),
54mM(isopropanol), 60mM(octanol), and 13mM(decanol).
For all compounds, we observe a downward shift of 4C
when added at their anesthetic dose. We note that this is
significantly larger than the ~1C downward shift observed
in the main chain transition temperature of DPPC with the
same concentration of n-alcohol anesthetic (17).Non–n-alcohol anesthetics also lower critical
temperatures at their anesthetic dose
To explore if our observations regarding n-alcohols could be
generalized to other liquid anesthetics, we also investigated
Anesthetics lower critical temperatures 2755the impacts of three additional anesthetic compounds in
Fig. 4. Isopropanol is an isomer of 1-propanol and has a
slightly reduced concentration required for blocking power
on motor fibers from sciatic nerves of frogs (351 mM vs.
218 mM) (48). If we rescale this value using the AC50 value
for 1-propanol to influence the righting reflex of tadpoles,
we estimate an AC50 value for isopropanol to be 87 mM,
as indicated in Fig. 4 A. At this concentration, the critical
temperature is depressed by ~4C, as is seen for n-alcohol
anesthetics. Phenylethanol (PEtOH) is a local anesthetic
that has been previously demonstrated to alter helix aggre-
gation in bacterial membranes and single component model
membranes (49). Again, we observe that adding PEtOH to
GPMVs acts to reduce critical temperatures, with a 4C
downward shift at ~25 mM. At a possibly more clinically
relevant concentration of 8mM (49), we observe a down-
ward shift of 2.5 5 0.4C. Finally, we explored the intra-
venous general anesthetic propofol, and again find that
propofol lowers critical temperatures when added to
GPMVs. Previous work has measured an AC50 value of
between 2.2 and 2.5 mM (50), and at this concentration we
observe a 2.1 5 0.3C downward shift in GPMV critical
temperature. For all three compounds, we observe a linear
concentration dependence with a negative y-intercept of
about –2C as was observed with other n-alcohols, indi-
cating nonlinearity at low concentrations. Overall, we find
that these compounds reveal the same pattern observed forFIGURE 4 Non–n-alcohol liquid anesthetics lower critical temperatures
at their anesthetic dose. Data points represent a weighted average over at
least two separate experiments and error bounds are propagated through
this average, as described in Methods. Lines are fits to all points excluding
0 mM for phenylethanol and propofol and <50 mM for isopropanol. The
estimated anesthetic doses for these compounds are indicated by dashed
lines and are determined as described in the main text. To see this figure
in color, go online.n-alcohol anesthetics, although in some cases the magnitude
is reduced.Membrane soluble molecules that are not
anesthetics do not lower critical temperatures
There are numerous hydrophobic small molecules that are
structurally similar to general anesthetics, but do not exhibit
any general anesthetic activity. One well-studied example is
long chain n-alcohols with n R 12. This so-called ‘‘anes-
thetic cutoff effect’’ has been used to argue against a
lipid-mediated mechanism of general anesthesia (e.g
(14,16)). Fig. 5 A shows that tetradecanol (n ¼ 14) does
not alter critical temperatures in GPMVs even when added
at concentrations up to 5 mM, which is the measured AC50
value for dodecanol (n ¼ 12). A second example of a hydro-
phobic small molecule without anesthetic activity is 2,6
diterbutylphenol (16) and is shown in Fig. 5 B. 2,6 diterbu-
tylphenol is structurally similar to propofol but contains two
additional methyl groups and is therefore more hydropho-
bic. Similar to tetradecanol, we again observe no shift in
critical temperatures when 2,6 diterbutylphenol is added
to suspensions of GPMVs, even at concentrations where
propofol decreases Tc by roughly 4
C.DISCUSSION
Our observation that liquid general anesthetics lower critical
temperatures in isolated GPMVs suggest that these com-
pounds could be a useful experimental tool for probing
the effects of lipid-mediated heterogeneity in a range ofFIGURE 5 Structurally similar nonanesthetics do not lower critical tem-
peratures. (A) Tetradecanol is an n-alcohol but is not active as a general
anesthetic. Tetradecanol does not lower critical temperatures when added
to GPMVs. The n-alcohol data for n % 10 is replotted from Fig. 3 C. (B)
2,6 diterbutylphenol is structurally similar to propofol but contains two
additional methyl groups and is not active as a general anesthetic. 2,6 diter-
butylphenol does not lower critical temperatures in GPMVs. The propofol
data are replotted from Fig. 4 C. To see this figure in color, go online.
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plasma membrane heterogeneity, a compound that acts to
lower Tc would also reduce the size, lifetime, and composi-
tional contrast of lipid-mediated domains in the plasma
membrane at physiological temperature. In this context,
liquid general anesthetics are expected to act as inhibitors
of lipid heterogeneity and should interfere with the func-
tioning of proteins or protein networks that exploit this
type of lipid structure to perform their cellular functions.
Unlike cholesterol reduction, which modulates the misci-
bility transition in GPMVs by reducing the surface fraction
of the Lo phase (31,51), liquid general anesthetics alter
membrane mixing properties while maintaining membranes
at a critical composition. We expect anesthetics to be use-
ful as a complimentary membrane perturbation to the
commonly used cholesterol modulation, by perturbing lipid
mediated heterogeneity through an alternate mechanism
(Fig. 6). Anesthetics may produce results that are easier to
interpret as lipid-mediated interactions will be reduced
without changing the surface area available to compounds
that have a strong preference for either the Lo or Ld phase.
In addition, liquid general anesthetics alter membrane mix-
ing properties without the large changes in global membrane
composition that accompany cholesterol reduction (52),
since cholesterol typically makes up ~40 mol% of the intactFIGURE 6 (A) Proposed schematic phase diagram of a cell membrane.
Normal physiological conditions (gray circle) reside above a miscibility
critical point (star) below which the membrane separates into coexisting
Lo and Ld phases. Contours are of constant correlation length as described
previously (26) and physiological conditions predicted to have a correlation
length of roughly 20 nm. At constant physiological temperature, addition of
general anesthetics is expected to shift membranes in the direction of the
red arrow (26), increasing the temperature difference from the critical point.
The more familiar perturbations of cholesterol depletion (loading) act to
decrease (increase) membrane order, acting like the green (yellow) arrows
on the phase diagram marked 2 and 4. (B) Perturbations affect the lateral
structure of the membrane as depicted schematically with snapshots from
a lattice Ising model, which shares broad features of its phase diagram.
Under physiological conditions (3), there is no macroscopic phase separa-
tion, but supercritical fluctuations lead to structure that is much larger than
the size of microscopic components, and there is roughly an equal area of
ordered and disordered components. The common perturbations of choles-
terol depletion (2) and loading (4) primarily act to increase the surface
fraction of disordered (white) or ordered (black) membrane respectively.
In contrast, liquid general anesthetics perturb membrane structure but do
not affect the ordered to disordered ratio (1). Instead they reduce the size,
lifetime, and contrast of fluctuations. To see this figure in color, go online.
Biophysical Journal 105(12) 2751–2759plasma membrane (53). Molecules that alter the Lo /Ld ratio
do so by partitioning into a preferred phase and thereby
increasing its area fraction. By contrast, components that
lower Tc must make the two phases more miscible. They
do this by partitioning less strongly to either phase than
typical components (54–56). Below Tc, this lowers the inter-
facial energy between macroscopic phases. Above Tc,
where there are no macroscopic phases, weakly partitioning
molecules that lower Tc will have a preference to localize to
the boundaries between the many small domains that are
present (54). This mechanism is distinct from freezing-point
depression, in which impurities that are excluded from one
phase lower transition temperatures into a solid state primar-
ily by raising the entropy of the liquid state.
We find it striking that the Tc lowering effect scales
remarkably well with anesthetic potency for the four
n-alcohol general anesthetics investigated. To the first order,
this is the expected result because n-alcohols become more
hydrophobic as n is increased and therefore partition more
strongly into membranes (13). However, this striking corre-
lation extends beyond the n-alcohol anesthetics to include
tetradecanol, an n-alcohol that is expected to strongly
partition into membranes but has no anesthetic potency.
We observe no downward shift in Tc in membranes contain-
ing tetradecanol, in good agreement with previous ESR
studies that demonstrated that tetradecanol does not alter
the ordering of natural membranes even at much higher
membrane concentrations (7). Tc is also not altered when
the propofol analog 2,6 diterbutylphenol is added to
GPMVs, again consistent with it lacking anesthetic activity.
For the molecules investigated in this study, the shift in Tc
more accurately predicts general anesthetic potency than
does membrane partitioning.
We observe a much larger shift in Tc than is expected
from a naı¨ve extrapolation of results in other membrane as-
says, which typically show changes that can be mimicked by
very small (<1C) changes in temperature (17). The magni-
tude of the anesthetic effect on the miscibility transition in
GPMVs also highlights the differences between the mem-
brane miscibility transition examined in this study and the
main chain melting transition present in single-component
membranes, where transition temperatures are reduced in
the presence of anesthetic through freezing-point depres-
sion. Previous work has demonstrated that miscibility tran-
sitions are generally more sensitive to perturbations in the
form of impurities (34–37,57). The miscibility transition
in GPMVs is also different than the main chain transition
in purified membranes in that it is a continuous, second-
order transition, tuned very close to its critical point
(Fig. 6). The miscibility critical point is distinguished by
an increased sensitivity of physical properties to changes
in its control parameters of temperature and composition.
Thus, a small shift in Tc could lead to large changes in phys-
ical properties at a fixed temperature. Although 4C is sub-
stantially larger than changes seen in most membrane
Anesthetics lower critical temperatures 2757assays, it is still smaller than the range of temperature expe-
rienced by cold-blooded anesthetic sensitive animals such as
tadpoles. It may be that these larger temperature shifts are
compensated for by mechanisms not sensitive to the pres-
ence of anesthetics.
In the context of general anesthesia, our findings
contribute to the current discussion regarding the molecular
mechanisms through which liquid general anesthetics act
on ligand-gated ion channels. Our results could have impli-
cations even in the context of a model where general
anesthetics act primarily through direct binding to these
ligand-gated ion channels. Our observations using synthetic
liquid anesthetics suggest that any endogenous ligands for
these sites would also share the property that they lower crit-
ical temperatures in plasma membranes. Such molecules
would also localize to domain boundaries and would affect
proteins differently depending on their microscopic locali-
zation. It is possible that putative anesthetic sites serve a
functional purpose by providing a means of coupling mem-
brane properties to the functioning of embedded proteins
through uncharacterized endogenous anesthetic ligands.
Indeed, many of the proteins implicated in mediating
sensitivity to anesthetics are regulated in part through their
localization (39–43).
Our results hint at the intriguing possibility that anes-
thetics may exert some of their influence on proteins
through their effects on the membrane’s miscibility
behavior. Previous authors have proposed models in which
anesthetics influence proteins by interfering with native
regulation by the membrane’s lateral pressure profile (58),
and in which other compounds influence protein function
through their effects on hydrophobic thickness and other
elastic properties (59,60). Plasma membrane composition
has been implicated in controlling the spatial localization
of membrane receptors and channels (39), and there is evi-
dence that many channels including those implicated in the
anesthetic response are localized in this fashion, including
the gamma aminobutyric acid A (GABA-A) receptor (42)
and the nicotinic acetylcholine receptor (nAchR) (61). It is
also possible that localization is tied in some way to func-
tion, either by providing a local lipid environment that either
promotes or suppresses channel activation, by bringing
receptors into close proximity with regulatory components,
or by tuning the interactions between components of a
regulatory network (see (62) and Fig. 6). Along these lines,
it has been shown that plasma membrane cholesterol levels
modulate the functioning of many ion channels (39),
including both GABA-A (43) and nAchR (41), although
these changes could be mediated by direct binding to
cholesterol or by specific interactions with neurosteroid
modulators (63).
In principle, an ion channel regulated through its prefer-
ences for a local lipid environment could have its gating
properties changed by any perturbation that modulates the
mixing properties of lipids, even without specific bindingof these compounds to the channels themselves. This
includes liquid general anesthetics, which in this study we
demonstrate lower critical temperatures in isolated plasma
membranes. Further experimental and modeling work is
required to clarify if this type of regulation plays an impor-
tant role in the specific case of functioning of the ligand-
gated ion channels responsible for general anesthesia, and
if the 4C shift observed in our study is adequate to signif-
icantly affect receptor functions. More generally, we expect
that liquid general anesthetics will interfere with the large
number of biological processes that have already been
postulated to make use of membrane ‘‘raft’’ heterogeneity
to compartmentalize and organize their function.
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